Early trial halted for new lymphoma pill
NCT ID NCT06106841
Summary
This early-stage study tested a new oral drug called TQB3909 in adults whose mantle cell lymphoma had returned or stopped responding to other treatments. The main goals were to find a safe dose for future testing and to closely monitor for any side effects. The trial was terminated early and enrolled 19 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MANTLE CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Cancer Hospital of Harbin Medical University
Harbin, Heilongjiang, 150081, China
-
Binzhou Medical University Hospital
Binzhou, Shandong, 256603, China
-
Chongqing University Hospital
Chongqing, Chongqing Municipality, 400030, China
-
Gansu Provincial Cancer Hospital
Lanzhou, Gansu, 730050, China
-
Guangxi Medical University Cancer Hospital
Nanning, Guangxi, 530021, China
-
Henan Cancer Hospital
Zhengzhou, Henan, 450000, China
-
Heping Hospital Affiliated to Changzhi Medical College
Changzhi, Shanxi, 046000, China
-
Institute of Dematology & Blood diseases Hospital
Tianjin, Tianjin Municipality, 300052, China
-
Jilin Cancer Hospital
Changchun, Jilin, 130012, China
-
Jinzhou Central Hospital
Wuxi, Jiangsu, 530031, China
-
Linyi People's Hospital
Linyi, Shandong, 276000, China
-
Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
-
Shanghai Huashan Hospital
Shanghai, Shanghai Municipality, 200040, China
-
The Affiliated Hospital of Chengde Medical College
Chengde, Hebei, 067000, China
-
The Affiliated Hospital of Southwest Medical University
Luzhou, Sichuan, 646000, China
-
The Affiliated Hospital of Xuzhou Medical University
Nanjing, Jiangsu, 220005, China
-
The First Affiliated Hospital Of Soochow University
Suzhou, Jiangsu, 215006, China
-
The First Affiliated Hospital of Ningbo University
Ningbo, Zhejiang, 215006, China
-
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, 361003, China
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310003, China
-
The First Hospital of Jilin University
Changchun, Jilin, 130022, China
-
The Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, 150001, China
-
The Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215004, China
-
The Second Hospital of Dalian Medical University
Dalian, Liaoning, 116000, China
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, 300040, China
-
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Wuhan, Hubei, 430050, China
-
Tongji hospital of Tongji University
Shanghai, Shanghai Municipality, 200065, China
-
Xinjiang Uygur Autonomous Region People's Hospital
Ürümqi, Xinjiang, 830001, China
Conditions
Explore the condition pages connected to this study.